Article info

Download PDFPDF
Extended report
Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study

Authors

  1. Correspondence to Dr John W Baddley, Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, 1900 University Boulevard, 229 Tinsley Harrison Tower, Birmingham, AL 35294-0006, USA; jbaddley{at}uab.edu
View Full Text

Citation

Baddley JW, Winthrop KL, Chen L, et al
Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study

Publication history

  • Received February 5, 2013
  • Revised May 21, 2013
  • Accepted July 1, 2013
  • First published July 13, 2013.
Online issue publication 
October 05, 2014

Article Versions